Michael P Manns

发表

Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure.

Christian Trautwein, Tom Luedde, Christian Liedtke, 2003, European cytokine network.

The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.

Korbinian Brand, Ralf Lichtinghagen, M. Manns, 2013, Journal of hepatology.

Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI).

M. Manns, M. Gebel, H. Wedemeyer, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.

M. Manns, T. Greten, F. Korangy, 2011, Blood.

Second-wave protease inhibitors: choosing an heir.

M. Manns, S. Ciesek, T. von Hahn, 2011, Clinics in liver disease.

Interleukin 6/gp130‐dependent pathways are protective during chronic liver diseases

Werner Müller, Ludger Leifeld, Christian Trautwein, 2003, Hepatology.

Implementation of proteomic biomarkers: making it work

Raymond Vanholder, Fulvio Magni, David Maahs, 2012, European journal of clinical investigation.

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

Christian Gieger, Euijung Ryu, Andre Franke, 2011, Nature Genetics.

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

Hans-Gustaf Ljunggren, Jerzy Jaroszewicz, Carlos A Guzmán, 2010, Gastroenterology.

Prospective biopsy‐controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis

Bernhard Vaske, M. Manns, K. Schulze-Osthoff, 2012, Hepatology.

Myeloid derived suppressor cells in human diseases.

M. Manns, T. Greten, F. Korangy, 2011, International immunopharmacology.

Prometheus--a new extracorporeal system for the treatment of liver failure.

M. Manns, D. Fliser, H. Haller, 2003, Journal of hepatology.

Utility of viral kinetics in HCV therapy – It is not over until it is over?

M. Manns, B. Maasoumy, Michael P Manns, 2019, Liver international : official journal of the International Association for the Study of the Liver.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

Kenneth Koury, Vinod K Rustgi, M. Manns, 2022 .

Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.

M. Manns, L. Zender, J. Buer, 2004, Genes & development.

The diagnosis and treatment of hepatocellular carcinoma.

M. Manns, T. Greten, Michael P Manns, 2014, Deutsches Arzteblatt international.

Boceprevir for untreated chronic HCV genotype 1 infection.

M. Manns, J. Albrecht, K. Reddy, 2011, The New England journal of medicine.

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Christian Trautwein, Albert Heim, Tom Luedde, 2004, Journal of virology.

Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data.

M. Manns, S. Kubicka, M. Kirstein, 2014, The oncologist.

Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells.

Thomas Gebhardt, M. Manns, S. Bischoff, 2003, The Journal of allergy and clinical immunology.